Literature DB >> 21641838

Circadian rhythms and cardiovascular health.

Francesco Portaluppi1, Ruana Tiseo, Michael H Smolensky, Ramón C Hermida, Diana E Ayala, Fabio Fabbian.   

Abstract

The functional organization of the cardiovascular system shows clear circadian rhythmicity. These and other circadian rhythms at all levels of organization are orchestrated by a central biological clock, the suprachiasmatic nuclei of the hypothalamus. Preservation of the normal circadian time structure from the level of the cardiomyocyte to the organ system appears to be essential for cardiovascular health and cardiovascular disease prevention. Myocardial ischemia, acute myocardial infarct, and sudden cardiac death are much greater in incidence than expected in the morning. Moreover, supraventricular and ventricular cardiac arrhythmias of various types show specific day-night patterns, with atrial arrhythmias--premature beats, tachycardias, atrial fibrillation, and flutter - generally being of higher frequency during the day than night--and ventricular fibrillation and ventricular premature beats more common, respectively, in the morning and during the daytime activity than sleep span. Furthermore, different circadian patterns of blood pressure are found in arterial hypertension, in relation to different cardiovascular morbidity and mortality risk. Such temporal patterns result from circadian periodicity in pathophysiological mechanisms that give rise to predictable-in-time differences in susceptibility-resistance to cyclic environmental stressors that trigger these clinical events. Circadian rhythms also may affect the pharmacokinetics and pharmacodynamics of cardiovascular and other medications. Knowledge of 24-h patterns in the risk of cardiac arrhythmias and cardiovascular disease morbidity and mortality plus circadian rhythm-dependencies of underlying pathophysiologic mechanisms suggests the requirement for preventive and therapeutic interventions is not the same throughout the day and night, and should be tailored accordingly to improve outcomes. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21641838     DOI: 10.1016/j.smrv.2011.04.003

Source DB:  PubMed          Journal:  Sleep Med Rev        ISSN: 1087-0792            Impact factor:   11.609


  67 in total

1.  CRY1, CRY2 and PRKCDBP genetic variants in metabolic syndrome.

Authors:  Leena Kovanen; Kati Donner; Mari Kaunisto; Timo Partonen
Journal:  Hypertens Res       Date:  2014-11-13       Impact factor: 3.872

2.  A twin study of genetic influences on diurnal preference and risk for alcohol use outcomes.

Authors:  Nathaniel F Watson; Dedra Buchwald; Kathryn Paige Harden
Journal:  J Clin Sleep Med       Date:  2013-12-15       Impact factor: 4.062

Review 3.  Circadian disruption: What do we actually mean?

Authors:  Céline Vetter
Journal:  Eur J Neurosci       Date:  2018-12-05       Impact factor: 3.386

Review 4.  Chronotherapeutics of conventional blood pressure-lowering medications: simple, low-cost means of improving management and treatment outcomes of hypertensive-related disorders.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Juan J Crespo; María T Ríos; Ana Moyá; Francesco Portaluppi
Journal:  Curr Hypertens Rep       Date:  2014-02       Impact factor: 5.369

Review 5.  Circadian rhythm connections to oxidative stress: implications for human health.

Authors:  Melissa Wilking; Mary Ndiaye; Hasan Mukhtar; Nihal Ahmad
Journal:  Antioxid Redox Signal       Date:  2013-04-24       Impact factor: 8.401

Review 6.  Chronotherapy improves blood pressure control and reduces vascular risk in CKD.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; Artemio Mojón; José R Fernández; Juan J Crespo; Ana Moyá; María T Ríos; Francesco Portaluppi
Journal:  Nat Rev Nephrol       Date:  2013-04-23       Impact factor: 28.314

Review 7.  Sleep-time ambulatory blood pressure as a novel therapeutic target for cardiovascular risk reduction.

Authors:  R C Hermida; D E Ayala; A Mojón; M H Smolensky; F Portaluppi; J R Fernández
Journal:  J Hum Hypertens       Date:  2014-02-06       Impact factor: 3.012

Review 8.  Chronotherapy with conventional blood pressure medications improves management of hypertension and reduces cardiovascular and stroke risks.

Authors:  Ramón C Hermida; Diana E Ayala; Michael H Smolensky; José R Fernández; Artemio Mojón; Francesco Portaluppi
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

9.  Circadian variation of heart rate variability across sleep stages.

Authors:  Philippe Boudreau; Wei-Hsien Yeh; Guy A Dumont; Diane B Boivin
Journal:  Sleep       Date:  2013-12-01       Impact factor: 5.849

Review 10.  Circadian Influence on Metabolism and Inflammation in Atherosclerosis.

Authors:  Cameron S McAlpine; Filip K Swirski
Journal:  Circ Res       Date:  2016-06-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.